Intravitreal ranibizumab as an adjunct to conventional surgery for neovascular glaucoma: a retrospective observational study of efficacy and clinical characteristics of surgical failure cases. (PubMed, Front Physiol) - Oct 1, 2026 - "This retrospective matched cohort study suggests that perioperative ranibizumab may be associated with more favorable IOP control and NVI-free status, although the 12-month surgical success rate did not reach statistical significance. These findings are exploratory and require confirmation in larger prospective studies."
Journal • Observational data • Retrospective data • Cardiovascular • Diabetes • Glaucoma • Metabolic Disorders • Ophthalmology
|